-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Synthetic routes of Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride (1:?) is a topic of great interest in the chemical industry.
This compound is used in various industrial applications, including as an intermediate in the production of pharmaceuticals and agrochemicals.
The demand for this compound has been increasing rapidly in recent years due to its diverse applications.
There are several synthetic routes to produce Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride (1:?), each with its own advantages and disadvantages.
The choice of synthetic route depends on various factors, including the desired purity of the product, the scale of production, and the cost of production.
One of the most common synthetic routes to produce Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride (1:?) involves the reaction of epichlorohydrin with 1-[3-(dimethylamino)propyl]-3-ethylcarbamide.
This reaction produces the desired compound after several steps, including reduction, alkylation, and hydrolysis.
Another synthetic route to produce Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride (1:?) involves the reaction of 1-[3-(dimethylamino)propyl]-3-ethylcarbamide with chloroacetyl chloride.
This reaction produces the desired compound after several steps, including reduction, alkylation, and hydrolysis.
Both of these synthetic routes have their own advantages and disadvantages.
For example, the first route involves several steps, including reduction, alkylation, and hydrolysis, which can increase the cost of production.
On the other hand, the second route uses chloroacetyl chloride, which can be expensive and difficult to handle.
Recently, a new synthetic route to produce Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride (1:?) has been developed.
This route involves the reaction of 1-[3-(dimethylamino)propyl]-3-ethylcarbamide with chloroform in the presence of a Lewis acid catalyst.
This reaction produces the desired compound after several steps, including reduction, alkylation, and hydrolysis.
This new synthetic route has several advantages over the previously established routes.
For example, it involves fewer steps, which can reduce the cost of production.
Additionally, the use of chloroform as a reactant can reduce the cost of production, as it is less expensive than epichlorohydrin and chloroacetyl chloride.
Furthermore, the use of a Lewis acid catalyst can improve the reaction efficiency, which can increase the yield of the desired product.
In conclusion, the synthetic routes of Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride (1:?) are essential in the chemical industry.
The choice of synthetic route depends on various factors, including the desired purity of the product, the scale of production, and the cost of production.
Recently, a new synthetic route has been developed that has several advantages over the previously established routes.
This new route involves the reaction of 1-[3-(dimethylamino)propyl]-3-ethylcarbamide with chloroform in the presence of a Lewis acid catalyst.